Article
Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype.
Arteriosclerosis, thrombosis, and vascular biology - 1 May 2015
McAlpine Cameron S, Huang Aric, Emdin Abby, Banko Nicole S, Beriault Daniel R, Shi Yuanyuan, Werstuck Geoff H
Abstract excerpt
OBJECTIVE: Glycogen synthase kinase (GSK)-3α/β has been implicated in the pathogenesis of diabetes mellitus, cancer, Alzheimer, and atherosclerosis. The tissue- and homolog-specific functions of GSK3α and β in atherosclerosis are unknown. This study examines the effect of hepatocyte or myeloid cell deletion of GSK3α or GSK3β on atherosclerosis in low-density lipoprotein receptor (LDLR)(-/-) mice. APPROACH AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
